FDA approves Lumvoa for active and chronic thyroid eye disease
The U.S. Food and Drug Administration has approved Lumvoa (veligrotug-vvze) to treat thyroid eye disease (TED), making it the first approved therapy for the condition with labeling that includes data… …
Latest Videos
See AllExplore Topic Centers
Anterior Segment
Cataract
Cornea and External Disease
Diabetic Macular Edema
Dry Eye
Early Onset Cataracts
Exclusives
General
Geographic Atrophy
Glaucoma
Industry News
Ocular Surface Disease
Oculoplastics
Pediatrics
Practice Management
Presbyopia
Refractive Surgery/Vision Correction
Residents & Young Ophthalmologists
Retina
Retinopathy of Prematurity
Trending Topics



















